Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence (original) (raw)

• Sharpless, N. E. & DePinho, R. A. Cancer: crime and punishment. Nature 436, 636–637 (2005)
  Article ADS CAS Google Scholar
• Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725–730 (2005)
  Article ADS CAS Google Scholar
• Xue, W. et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656–660 (2007)
  Article CAS Google Scholar
• Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661–665 (2007)
  Article CAS Google Scholar
• Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660–665 (2005)
  Article ADS CAS Google Scholar
• Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720–724 (2005)
  Article ADS CAS Google Scholar
• Collado, M. et al. Tumour biology: senescence in premalignant tumours. Nature 436, 642 (2005)
  Article ADS CAS Google Scholar
• Cantley, L. C. & Neel, B. G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl Acad. Sci. USA 96, 4240–4245 (1999)
  Article ADS CAS Google Scholar
• Di Cristofano, A. & Pandolfi, P. P. The multiple roles of PTEN in tumor suppression. Cell 100, 387–390 (2000)
  Article CAS Google Scholar
• Salmena, L., Carracedo, A. & Pandolfi, P. P. Tenets of PTEN tumor suppression. Cell 133, 403–414 (2008)
  Article CAS Google Scholar
• Bloom, J. & Pagano, M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 13, 41–47 (2003)
  Article CAS Google Scholar
• Nakayama, K. I. & Nakayama, K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 16, 323–333 (2005)
  Article CAS Google Scholar
• Gstaiger, M. et al. Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl Acad. Sci. USA 98, 5043–5048 (2001)
  Article ADS CAS Google Scholar
• Latres, E. et al. Role of the F-box protein Skp2 in lymphomagenesis. Proc. Natl Acad. Sci. USA 98, 2515–2520 (2001)
  Article ADS CAS Google Scholar
• Shim, E. H. et al. Expression of the F-box protein SKP2 induces hyperplasia, dysplasia, and low-grade carcinoma in the mouse prostate. Cancer Res. 63, 1583–1588 (2003)
  CAS PubMed Google Scholar
• Lin, H. K. et al. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nature Cell Biol. 11, 420–432 (2009)
  Article ADS CAS Google Scholar
• Chiarle, R. et al. S-phase kinase-associated protein 2 expression in non-Hodgkin’s lymphoma inversely correlates with p27 expression and defines cells in S phase. Am. J. Pathol. 160, 1457–1466 (2002)
  Article CAS Google Scholar
• Nakayama, K. et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27_Kip1_, polyploidy and centrosome overduplication. EMBO J. 19, 2069–2081 (2000)
  Article CAS Google Scholar
• Lin, A. W. et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12, 3008–3019 (1998)
  Article CAS Google Scholar
• Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593–602 (1997)
  Article CAS Google Scholar
• Kim, W. Y. & Sharpless, N. E. The regulation of INK4/ARF in cancer and aging. Cell 127, 265–275 (2006)
  Article CAS Google Scholar
• Yaswen, P. & Campisi, J. Oncogene-induced senescence pathways weave an intricate tapestry. Cell 128, 233–234 (2007)
  Article CAS Google Scholar
• Hemann, M. T. et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nature Genet. 33, 396–400 (2003)
  Article CAS Google Scholar
• Gottlieb, E., Haffner, R., von Ruden, T., Wagner, E. F. & Oren, M. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J. 13, 1368–1374 (1994)
  Article CAS Google Scholar
• Chen, Z. et al. Differential p53-independent outcomes of p19Arf loss in oncogenesis. Sci. Signal. 2, ra44 (2009)
  PubMed PubMed Central Google Scholar
• Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633–637 (2006)
  Article ADS CAS Google Scholar
• Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638–642 (2006)
  Article ADS CAS Google Scholar
• Mallette, F. A., Gaumont-Leclerc, M. F. & Ferbeyre, G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev. 21, 43–48 (2007)
  Article CAS Google Scholar
• Yu, Z. K., Gervais, J. L. & Zhang, H. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21CIP1/WAF1and cyclin D proteins. Proc. Natl Acad. Sci. USA 95, 11324–11329 (1998)
  Article ADS CAS Google Scholar
• Denoyelle, C. et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nature Cell Biol. 8, 1053–1063 (2006)
  Article CAS Google Scholar
• Kim, I., Xu, W. & Reed, J. C. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nature Rev. Drug Discov. 7, 1013–1030 (2008)
  Article CAS Google Scholar
• Di Cristofano, A. et al. Impaired Fas response and autoimmunity in Pten+/- mice. Science 285, 2122–2125 (1999)
  Article CAS Google Scholar
• Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nature Genet. 19, 348–355 (1998)
  Article CAS Google Scholar
• Kamijo, T., Bodner, S., van de Kamp, E., Randle, D. H. & Sherr, C. J. Tumor spectrum in ARF-deficient mice. Cancer Res. 59, 2217–2222 (1999)
  CAS PubMed Google Scholar
• Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19_ARF_. Cell 91, 649–659 (1997)
  Article CAS Google Scholar
• Soucy, T. A. et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458, 732–736 (2009)
  Article ADS CAS Google Scholar
• Young, A. P. et al. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nature Cell Biol. 10, 361–369 (2008)
  Article ADS CAS Google Scholar
• Kuo, Y. L. & Giam, C. Z. Activation of the anaphase promoting complex by HTLV-1 tax leads to senescence. EMBO J. 25, 1741–1752 (2006)
  Article CAS Google Scholar
• Agarwal, A. et al. Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease. Blood 112, 1960–1970 (2008)
  Article CAS Google Scholar
• Lin, H. K., Bergmann, S. & Pandolfi, P. P. Cytoplasmic PML function in TGF-β signalling. Nature 431, 205–211 (2004)
  Article ADS CAS Google Scholar
• Yang, W. L. et al. The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science 325, 1134–1138 (2009)
  Article ADS CAS Google Scholar
• Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725–730 (2005)
  Article ADS CAS Google Scholar